Regulation of pattern recognition receptors by the apolipoprotein A-I mimetic peptide 4F

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 32, Issue 11, 2012, Pages 2631-2639

  White, C Roger ^a,b   Smythies, Lesley E ^a   Crossman, David K ^c,d   Palgunachari, Mayakonda N ^a   Anantharamaiah, G M ^a,e   Datta, Geeta ^a  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Apolipoprotein mimetic peptide; Inflammation; Macrophage; Microarray analysis; Toll like receptor signaling

Indexed keywords

APOLIPOPROTEIN A1; CAVEOLIN; CD14 ANTIGEN; CHOLESTEROL; INTERFERON REGULATORY FACTOR 3; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MYELOID DIFFERENTIATION FACTOR 88; TANK BINDING KINASE 1; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; AP 4F PEPTIDE; AP-4F PEPTIDE; AUTACOID; CAV1 PROTEIN, HUMAN; CAVEOLIN 1; CYTOKINE; PEPTIDE; RELA PROTEIN, HUMAN; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR RELA;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MACROPHAGE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; ACTIVE TRANSPORT; CELL CULTURE; CELL MEMBRANE; DNA MICROARRAY; DRUG EFFECT; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; GENETICS; IMMUNOLOGY; INFLAMMATION; METABOLISM; METHODOLOGY; PHOSPHORYLATION; TIME;

ACTIVE TRANSPORT, CELL NUCLEUS; ANTI-INFLAMMATORY AGENTS; APOLIPOPROTEIN A-I; CAVEOLIN 1; CELLS, CULTURED; CHOLESTEROL; CYTOKINES; DOWN-REGULATION; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MACROPHAGES; MEMBRANE MICRODOMAINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PEPTIDES; PHOSPHORYLATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TIME FACTORS; TOLL-LIKE RECEPTORS; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION, GENETIC;

EID: 84871886897     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.112.300167     Document Type: Article

References (33)

1. Castelli WP. Cholesterol and lipids in the risk of coronary artery disease-the Framingham Heart Study. Can J Cardiol. 1988;5A-10A.
2. Nissen SE, Tsunoda T, Tuzcu EM, Schoenhagen P, Cooper CJ, Yasin M, Eaton GM, Lauer MA, Sheldon WS, Grines CL, Halpern S, Crowe T, Blankenship JC, Kerensky R. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA. 2003;290:2292-2300.
3. Moore RE, Navab M, Millar JS, Zimetti F, Hama S, Rothblat GH, Rader DJ. Increased atherosclerosis in mice lacking apolipoprotein A-I attributable to both impaired reverse cholesterol transport and increased infam-mation. Circ Res. 2005;97:763-771.
4. Anantharamaiah GM. Synthetic peptide analogs of apolipoproteins. Meth Enzymol. 1986;128:627-647.
5. Datta G, Chaddha M, Hama S, Navab M, Fogelman AM, Garber DW, Mishra VK, Epand RM, Epand RF, Lund-Katz S, Phillips MC, Segrest JP, Anantharamaiah GM. Effects of increasing hydrophobicity on the physical-chemical and biological properties of a class A amphipathic helical peptide. J Lipid Res. 2001;42:1096-1104.
6. White CR, Datta G, Mochon P, Zhang Z, Kelly O, Curcio C, Parks D, Palgunachari M, Handattu S, Gupta H, Garber DW, Anantharamaiah GM. Vasculoprotective effects of apolipoprotein mimetic peptides: an evolving paradigm in hdl therapy. Vasc Dis Prev. 2009;6:122-130.
7. Navab M, Anantharamaiah GM, Reddy ST, Fogelman AM. Apolipoprotein A-I mimetic peptides and their role in atherosclerosis prevention. Nat Clin Pract Cardiovasc Med. 2006;3:540-547.
8. Smythies LE, White CR, Maheshwari A, Palgunachari MN, Anantharamaiah GM, Chaddha M, Kurundkar AR, Datta G. Apolipoprotein A-I mimetic 4F alters the function of human monocyte-derived macro-phages. Am J Physiol, Cell Physiol. 2010;298:C1538-C1548.
9. Navab M, Yu R, Gharavi N, Huang W, Ezra N, Lotfzadeh A, Anantharamaiah GM, Alipour N, Van Lenten BJ, Reddy ST, Marelli D. High-density lipoprotein: antioxidant and anti-infammatory properties. Curr Atheroscler Rep. 2007;9:244-248.
10. Van Lenten BJ, Wagner AC, Jung CL, Ruchala P, Waring AJ, Lehrer RI, Watson AD, Hama S, Navab M, Anantharamaiah GM, Fogelman AM. Anti-infammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affnity than human apoA-I. J Lipid Res. 2008;49:2302-2311.
11. Martinez FO, Gordon S, Locati M, Mantovani A. Transcriptional pro-fling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol. 2006;177:7303-7311.
12. Chang ZL. Important aspects of Toll-like receptors, ligands and their signaling pathways. Infamm Res. 2010;59:791-808.
13. Smythies LE, Shen R, Bimczok D, Novak L, Clements RH, Eckhoff DE, Bouchard P, George MD, Hu WK, Dandekar S, Smith PD. Infammation anergy in human intestinal macrophages is due to Smad-induced IkappaBalpha expression and NF-kappaB inactivation. J Biol Chem. 2010;285:19593-19604.
14. Benjamini B, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Statist. Soc. B. 1995;57:289-300.
15. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003;4:249-264.
16. Gaus K, Rodriguez M, Ruberu KR, Gelissen I, Sloane TM, Kritharides L, Jessup W. Domain-specifc lipid distribution in macrophage plasma membranes. J Lipid Res. 2005;46:1526-1538.
17. Zhu X, Owen JS, Wilson MD, Li H, Griffths GL, Thomas MJ, Hiltbold EM, Fessler MB, Parks JS. Macrophage ABCA1 reduces MyD88-dependent Toll-like receptor traffcking to lipid rafts by reduction of lipid raft cholesterol. J Lipid Res. 2010;51:3196-3206.
18. Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol. 2010;11:373-384.
19. Takeda K, Akira S. TLR signaling pathways. Semin Immunol. 2004;16:3-9.
20. Sakurai H, Chiba H, Miyoshi H, Sugita T, Toriumi W. IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactiva-tion domain. J Biol Chem. 1999;274:30353-30356.
21. Viatour P, Merville MP, Bours V, Chariot A. Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and infamma-tion. Trends Biochem Sci. 2005;30:43-52.
22. Sherman CB, Peterson SJ, Frishman WH. Apolipoprotein A-I mimetic peptides: a potential new therapy for the prevention of atherosclerosis. Cardiol Rev. 2010;18:141-147.
23. Razani B, Woodman SE, Lisanti MP. Caveolae: from cell biology to animal physiology. Pharmacol Rev. 2002;54:431-467.
24. Yvan-Charvet L, Welch C, Pagler TA, Ranalletta M, Lamkanf M, Han S, Ishibashi M, Li R, Wang N, Tall AR. Increased infammatory gene expression in ABC transporter-defcient macrophages: free cholesterol accumulation, increased signaling via toll-like receptors, and neu-trophil infltration of atherosclerotic lesions. Circulation. 2008;118: 1837-1847.
25. Koseki M, Hirano K, Masuda D, Ikegami C, Tanaka M, Ota A, Sandoval JC, Nakagawa-Toyama Y, Sato SB, Kobayashi T, Shimada Y, Ohno-Iwashita Y, Matsuura F, Shimomura I, Yamashita S. Increased lipid rafts and accelerated lipopolysaccharide-induced tumor necrosis factor-alpha secretion in Abca1-defcient macrophages. J Lipid Res. 2007;48:299-306.
26. Latz E, Visintin A, Lien E, Fitzgerald KA, Monks BG, Kurt-Jones EA, Golenbock DT, Espevik T. Lipopolysaccharide rapidly traffcs to and from the Golgi apparatus with the toll-like receptor 4-MD-2-CD14 complex in a process that is distinct from the initiation of signal transduction. J Biol Chem. 2002;277:47834-47843.
27. White CR, Anantharamaiah GM, Datta G. HDL mimetic peptides: novel therapeutic strategies for the treatment of infammatory vascular disease. In: Tsugikazu Komoda, ed. The HDL Handbook. London, UK: Academic Press; 2010.
28. Zhang Z, Datta G, Zhang Y, Miller AP, Mochon P, Chen YF, Chatham J, Anantharamaiah GM, White CR. Apolipoprotein A-I mimetic peptide treatment inhibits infammatory responses and improves survival in septic rats. Am J Physiol Heart Circ Physiol. 2009;297:H866-H873.
29. Guha M, Mackman N. LPS induction of gene expression in human monocytes. Cell Signal. 2001;13:85-94.
30. Fessler MB, Parks JS. Intracellular lipid fux and membrane micro-domains as organizing principles in infammatory cell signaling. J Immunol. 2011;187:1529-1535.
31. Zhu X, Lee JY, Timmins JM, Brown JM, Boudyguina E, Mulya A, Gebre AK, Willingham MC, Hiltbold EM, Mishra N, Maeda N, Parks JS. Increased cellular free cholesterol in macrophage-specifc Abca1 knock-out mice enhances pro-infammatory response of macrophages. J Biol Chem. 2008;283:22930-22941.
32. Triantaflou M, Manukyan M, Mackie A, Morath S, Hartung T, Heine H, Triantaflou K. Lipoteichoic acid and toll-like receptor 2 internaliza-tion and targeting to the Golgi are lipid raft-dependent. J Biol Chem. 2004;279:40882-40889.
33. Triantaflou M, Gamper FG, Haston RM, Mouratis MA, Morath S, Hartung T, Triantaflou K. Membrane sorting of toll-like receptor (TLR)-2/6 and TLR2/1 heterodimers at the cell surface determines hetero-typic associations with CD36 and intracellular targeting. J Biol Chem. 2006;281:31002-31011.